The Landscape of Atypical and Eukaryotic Protein Kinases
- PMID: 31677919
- DOI: 10.1016/j.tips.2019.09.002
The Landscape of Atypical and Eukaryotic Protein Kinases
Abstract
Kinases are attractive anticancer targets due to their central role in the growth, survival, and therapy resistance of tumor cells. This review explores the two primary kinase classes, the eukaryotic protein kinases (ePKs) and the atypical protein kinases (aPKs), and provides a structure-centered comparison of their sequences, structures, hydrophobic spines, mutation and SNP hotspots, and inhibitor interaction patterns. Despite the limited sequence similarity between these two classes, atypical kinases commonly share the archetypical kinase fold but lack conserved eukaryotic kinase motifs and possess altered hydrophobic spines. Furthermore, atypical kinase inhibitors explore only a limited number of binding modes both inside and outside the orthosteric binding site. The distribution of genetic variations in both classes shows multiple ways they can interfere with kinase inhibitor binding. This multilayered review provides a research framework bridging the eukaryotic and atypical kinase classes.
Keywords: SNP; catalytic kinase domain structures; eukaryotic and atypical protein kinases; oncogenic mutations; selective kinase inhibitor design; small-molecule kinase inhibitors.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.Annu Rev Biochem. 2011;80:769-95. doi: 10.1146/annurev-biochem-090308-173656. Annu Rev Biochem. 2011. PMID: 21548788 Review.
-
Small molecule kinase inhibitors as anti-cancer therapeutics.Mini Rev Med Chem. 2012 May;12(5):399-411. doi: 10.2174/138955712800493915. Mini Rev Med Chem. 2012. PMID: 22303944 Review.
-
Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.Biochim Biophys Acta. 2013 Jul;1834(7):1322-9. doi: 10.1016/j.bbapap.2013.02.040. Epub 2013 Mar 14. Biochim Biophys Acta. 2013. PMID: 23499783
-
Characterizing activities of eukaryotic-like protein kinases with atypical catalytic loop motifs from Myxococcus xanthus.J Biosci Bioeng. 2015 May;119(5):511-4. doi: 10.1016/j.jbiosc.2014.10.002. Epub 2014 Nov 1. J Biosci Bioeng. 2015. PMID: 25454605
-
INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.Pac Symp Biocomput. 2016;21:45-56. Pac Symp Biocomput. 2016. PMID: 26776172
Cited by
-
A human kinase yeast array for the identification of kinases modulating phosphorylation-dependent protein-protein interactions.Mol Syst Biol. 2022 Mar;18(3):e10820. doi: 10.15252/msb.202110820. Mol Syst Biol. 2022. PMID: 35225431 Free PMC article.
-
Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases.J Nat Prod. 2023 Oct 27;86(10):2283-2293. doi: 10.1021/acs.jnatprod.3c00394. Epub 2023 Oct 16. J Nat Prod. 2023. PMID: 37843072 Free PMC article.
-
Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity.Biochem J. 2020 Dec 11;477(23):4603-4621. doi: 10.1042/BCJ20200506. Biochem J. 2020. PMID: 33306089 Free PMC article. Review.
-
Compounds from Natural Sources as Protein Kinase Inhibitors.Biomolecules. 2020 Nov 12;10(11):1546. doi: 10.3390/biom10111546. Biomolecules. 2020. PMID: 33198400 Free PMC article. Review.
-
Deep Learning-Based Modeling of Drug-Target Interaction Prediction Incorporating Binding Site Information of Proteins.Interdiscip Sci. 2023 Jun;15(2):306-315. doi: 10.1007/s12539-023-00557-z. Epub 2023 Mar 26. Interdiscip Sci. 2023. PMID: 36967455 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
